B. Helpap

3.5k total citations
233 papers, 2.5k citations indexed

About

B. Helpap is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, B. Helpap has authored 233 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Pulmonary and Respiratory Medicine, 75 papers in Surgery and 30 papers in Oncology. Recurrent topics in B. Helpap's work include Prostate Cancer Treatment and Research (65 papers), Prostate Cancer Diagnosis and Treatment (44 papers) and Urologic and reproductive health conditions (27 papers). B. Helpap is often cited by papers focused on Prostate Cancer Treatment and Research (65 papers), Prostate Cancer Diagnosis and Treatment (44 papers) and Urologic and reproductive health conditions (27 papers). B. Helpap collaborates with scholars based in Germany, United States and Switzerland. B. Helpap's co-authors include Jens Köllermann, Lars Egevad, Harold Cremer, W. Maurer, P. Gedigk, Takanori Hattori, H Breining, David G. Bostwick, Rodolfo Montironi and Günter Klöppel and has published in prestigious journals such as Cancer, International Journal of Cancer and Cellular and Molecular Life Sciences.

In The Last Decade

B. Helpap

225 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Helpap Germany 26 1.2k 739 460 445 439 233 2.5k
Galina Pizov Israel 25 812 0.7× 605 0.8× 766 1.7× 460 1.0× 373 0.8× 67 2.6k
Pamela D. Unger United States 31 1.1k 0.9× 992 1.3× 602 1.3× 522 1.2× 478 1.1× 138 3.1k
S. Rannikko Finland 27 2.1k 1.7× 316 0.4× 490 1.1× 507 1.1× 313 0.7× 100 3.0k
Jorge L. Yao United States 32 2.0k 1.6× 1.0k 1.4× 940 2.0× 314 0.7× 691 1.6× 74 3.4k
Hugh A.�G. Fisher United States 27 1.3k 1.1× 778 1.1× 733 1.6× 329 0.7× 613 1.4× 60 2.8k
Masatsugu Iwamura Japan 27 1.3k 1.1× 795 1.1× 773 1.7× 278 0.6× 822 1.9× 204 2.9k
Guido Seitz Germany 24 907 0.7× 681 0.9× 530 1.2× 240 0.5× 380 0.9× 138 2.1k
Stephen M. Bonsib United States 32 1.7k 1.4× 606 0.8× 1.4k 3.1× 200 0.4× 355 0.8× 91 3.4k
Sophie Ferlicot France 29 825 0.7× 628 0.8× 902 2.0× 248 0.6× 454 1.0× 124 2.5k
James L. Bennington United States 25 637 0.5× 363 0.5× 910 2.0× 143 0.3× 595 1.4× 49 2.2k

Countries citing papers authored by B. Helpap

Since Specialization
Citations

This map shows the geographic impact of B. Helpap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Helpap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Helpap more than expected).

Fields of papers citing papers by B. Helpap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Helpap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Helpap. The network helps show where B. Helpap may publish in the future.

Co-authorship network of co-authors of B. Helpap

This figure shows the co-authorship network connecting the top 25 collaborators of B. Helpap. A scholar is included among the top collaborators of B. Helpap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Helpap. B. Helpap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Helpap, B., et al.. (2015). The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer. Pathology & Oncology Research. 22(2). 349–356. 15 indexed citations
2.
Helpap, B.. (2005). Kleine suspekte Prostataläsionen. Der Pathologe. 26(6). 398–404. 4 indexed citations
3.
Helpap, B., et al.. (2004). Therapieinduzierte Tumorregression des Prostatakarzinoms. Der Pathologe. 25(6). 461–468. 2 indexed citations
4.
Helpap, B., Bernd J. Schmitz‐Dräger, Peter W. Hamilton, et al.. (2003). Molecular pathology of non-invasive urothelial carcinomas (part I). Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 442(4). 309–316. 32 indexed citations
6.
Helpap, B., et al.. (2000). Nondetected Tumor (pT0) after Prolonged, Neoadjuvant Treatment of Localized Prostatic Carcinoma. European Urology. 38(6). 714–720. 30 indexed citations
7.
Helpap, B. & Jens Köllermann. (1999). Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 434(5). 385–391. 66 indexed citations
8.
Montironi, Rodolfo, David G. Bostwick, Helmut Bonkhoff, et al.. (1996). Workgroup 1: Origins of prostate cancer. Cancer. 78(2). 362–365. 41 indexed citations
9.
Helpap, B., et al.. (1995). Nucleolar and AgNOR-analysis of Prostatic Intraepithelial Neoplasia (PIN), Atypical Adenomatous Hyperplasia (AAH) and Prostatic Carcinoma. Pathology - Research and Practice. 191(5). 381–390. 23 indexed citations
10.
Helpap, B., et al.. (1995). Nucleolar organizer regions in low- and high-grade carcinomas of the prostate. World Journal of Urology. 13(3). 195–9. 4 indexed citations
11.
Schmid, Kurt Werner, B. Helpap, Martin Tötsch, et al.. (1994). Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic and neoplastic prostate. Histopathology. 24(3). 233–239. 42 indexed citations
12.
Helpap, B., et al.. (1991). Histological and immunohistochemical findings of prostatic carcinoma after external or interstitial radiotherapy. Journal of Cancer Research and Clinical Oncology. 117(6). 608–614. 15 indexed citations
13.
Helpap, B., et al.. (1985). [Classification, histological and cytological grading and assessment of regression grading in prostatic carcinomas. A recommendation of the Pathologic-Urological Task Force on Prostatic Carcinoma].. PubMed. 6(1). 3–7. 24 indexed citations
14.
Helpap, B.. (1984). Der Megakaryozyt : Morpholgie, Funktion, Zellkinetik und Regulation. Thieme eBooks. 1 indexed citations
15.
Ablin, Richard J., Gabriele Fontana, & B. Helpap. (1982). Cryoimmunotherapy: a Conference Report. European Surgical Research. 14(4). 309–316. 5 indexed citations
16.
Marklein, G., et al.. (1980). Keimbesiedlung der Gallenwege: Experimentelle Hinweise auf einen entero-hepatico-biliren Bakterienkreislauf. Langenbecks Archiv für Chirurgie. 353(2). 121–127. 3 indexed citations
17.
Helpap, B.. (1978). Extraadrenale Paraganglien und Paragangliome. Thieme eBooks. 6 indexed citations
18.
Helpap, B., et al.. (1977). [Comparison between frozen section histology and touch cytology of the breast].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 95(25). 2119–20. 2 indexed citations
19.
Helpap, B.. (1977). Malignant papillomatosis of the intrahepatic bile ducts.. PubMed. 24(6). 419–25. 33 indexed citations
20.
Helpap, B., et al.. (1974). [The cell composition of the red pulp of mice. II. Electronmicroscopic and autoradiographic investigations on megakaryocytes (author's transl)].. PubMed. 16(4). 347–61. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026